These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6245890)

  • 1. Genetics of resistance to lymphoma development in crosses between CBA and AKR strains.
    Tuffrey M; Hilgers J; Barnes RD
    Eur J Cancer (1965); 1980 Mar; 16(3):369-74. PubMed ID: 6245890
    [No Abstract]   [Full Text] [Related]  

  • 2. The apparent lack of association of antibody activity to murine leukemia virus and lymphoma development in (AKR x CBA) F1 mice.
    Barnes RD; Tuffrey M; Holmes HC
    Eur J Cancer (1965); 1981 Jan; 17(1):93-8. PubMed ID: 6266833
    [No Abstract]   [Full Text] [Related]  

  • 3. Failure to detect anti-group-specific murine leukemia virus activity in tetraparental AKR-CBA chimeras.
    Barnes RD; Tuffrey MA; Bourne RC
    Cancer Res; 1975 Oct; 35(10):2699-703. PubMed ID: 168964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous and induced appearance of murine leukemia virus antigen containing cells in organ cultures of embryonic mouse thymus.
    Riesenfeld I; Alm GV
    Int J Cancer; 1977 Aug; 20(2):309-17. PubMed ID: 70415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of C-type viral p30 antigens in lymphoma-resistant mice.
    Barnes RD; Tuffrey MA; Crewe P; Dawson L; Brown K; Joyner J
    Cancer Res; 1976 Oct; 36(10):3622-4. PubMed ID: 182358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of correlation of onset of lymphomas and levels of murine leukaemia virus in (AKR X CBA/H-T6Crc) F1.
    Barnes RD; Tuffrey M; Simpson M
    Eur J Cancer (1965); 1979 Aug; 15(8):1043-9. PubMed ID: 510342
    [No Abstract]   [Full Text] [Related]  

  • 7. Murine leukaemia virus group-specific antigen in tumor-resistant tetraparental AKR reversible CBA/H-T6 chimaeras.
    Barnes RD; Tuffrey M; Holliday J; Hilgers JH; Souissi T
    Br J Cancer; 1976 Jul; 34(1):28-38. PubMed ID: 182191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic study of lymphoma induction by Friend murine leukemia virus in crosses involving AKR mice.
    Silver J
    J Natl Cancer Inst; 1986 Sep; 77(3):793-9. PubMed ID: 3462416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genes affecting mink cell focus-inducing (MCF) murine leukemia virus infection and spontaneous lymphoma in AKR F1 hybrids.
    Rowe WP; Hartley JW
    J Exp Med; 1983 Aug; 158(2):353-64. PubMed ID: 6224881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of infectious murine leukemia virus and virus-related antigens in genetic crosses between AKR and the Fv-1 compatible strain C57L.
    Ikeda H; Rowe WP; Boyse EA; Stockert E; Sato H; Jacobs S
    J Exp Med; 1976 Jan; 143(1):32-46. PubMed ID: 172587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of antigens coded in murine leukemia viruses on thymocytes of allogeneic donor origin in AKR mice following syngeneic or allogeneic bone marrow transplantation.
    Wustrow TP; Good RA
    Cancer Res; 1985 Dec; 45(12 Pt 1):6428-35. PubMed ID: 2998600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternally transmitted resistance to lymphoma development in mice of reciprocal crosses of the RF/J and AKR/J strains.
    Mayer A; Struuck FD; Duran-Reynals ML; Lilly F
    Cell; 1980 Feb; 19(2):431-6. PubMed ID: 6244110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus expression and immunoprophylaxis of a murine lymphoma.
    Sekine I; Vredevoe DL; Hays EF
    J Natl Cancer Inst; 1975 Mar; 54(3):727-31. PubMed ID: 164567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of endogenous murine leukemia virus by maternal resistance factor.
    Melamedoff M; Lilly F; Duran-Reynals ML
    J Exp Med; 1983 Aug; 158(2):506-14. PubMed ID: 6310018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fv-1 regulation of lymphoma development and of thymic ecotropic and xenotropic MuLV expression in mice of the AKR/J x RF/J cross.
    Mayer A; Duran-Reynals ML; Lilly F
    Cell; 1978 Oct; 15(2):429-35. PubMed ID: 214239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine leukaemia virus expression in the AKR following thymectomy.
    Tuffrey M; Crewe P; Dawson L; Holliday J; Barnes RD
    Br J Cancer; 1975 Oct; 32(4):465-70. PubMed ID: 174705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restriction of C-type viral antigen in H-2/Fv-1 syngeneic mouse somatic cell hybrids.
    Kuzumaki N; Hilgers J; Moerkerk P; Ber R; Asjö B; Wiener F; Klein G
    Intervirology; 1980; 13(4):201-8. PubMed ID: 6248481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-surface and virion-envelope antigens shared by radiation leukemia virus (RadLV) and other murine c-type viruses.
    Ferrer JF
    Int J Cancer; 1973 Sep; 12(2):378-88. PubMed ID: 4134124
    [No Abstract]   [Full Text] [Related]  

  • 19. Lymphoma development from transplanted murine leukemia virus infected organ cultured thymuses: inhibitory effect of in vitro interferon treatment.
    Riesenfeld I; Tufveson G; Alm GV
    Int J Cancer; 1980 Apr; 25(4):529-34. PubMed ID: 6154660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The GIX antigen of murine leukemia virus: an analysis with monoclonal antibodies.
    Pierotti M; DeLeo AB; Pinter A; O'Donnell PV; Hämmerling U; Fleissner E
    Virology; 1981 Jul; 112(2):450-60. PubMed ID: 6167060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.